Elledge RM - Search Results

1

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Chang J, et al. Among authors: elledge rm. Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083. Cancer. 2003. PMID: 12548595 Free article.

2

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S, Elledge R. Massarweh S, et al. Breast Cancer Res Treat. 2011 Oct;129(3):819-27. doi: 10.1007/s10549-011-1679-8. Epub 2011 Jul 27. Breast Cancer Res Treat. 2011. PMID: 21792626 Free PMC article. Clinical Trial.

3

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham YL, Kalidas M, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, Lewis MT, Wong H, O'Connell P. Chang JC, et al. J Clin Oncol. 2005 Feb 20;23(6):1169-77. doi: 10.1200/JCO.2005.03.156. J Clin Oncol. 2005. PMID: 15718313

4

A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.

Massarweh S, Romond E, Black EP, Van Meter E, Shelton B, Kadamyan-Melkumian V, Stevens M, Elledge R. Massarweh S, et al. Breast Cancer Res Treat. 2014 Jan;143(2):325-32. doi: 10.1007/s10549-013-2810-9. Epub 2013 Dec 11. Breast Cancer Res Treat. 2014. PMID: 24327334 Clinical Trial.

5

Paget disease of a nipple graft following completion of a breast reconstruction with a nipple-sharing technique.

Basu CB, Wahba M, Bullocks JM, Elledge R. Basu CB, et al. Ann Plast Surg. 2008 Feb;60(2):144-5. doi: 10.1097/SAP.0b013e31806a592b. Ann Plast Surg. 2008. PMID: 18216504

6

Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study.

Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blanchard DK, Fisher RE, Chiang SB, Elledge R, Mawad ME. Sevick-Muraca EM, et al. Radiology. 2008 Mar;246(3):734-41. doi: 10.1148/radiol.2463070962. Epub 2008 Jan 25. Radiology. 2008. PMID: 18223125 Free PMC article.

7

A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer.

Niravath P, Tham YL, Wang T, Rodriguez A, Foreman C, Hilsenbeck SG, Elledge R, Rimawi M. Niravath P, et al. Oncologist. 2015 Jan;20(1):13. doi: 10.1634/theoncologist.2014-0278. Epub 2014 Nov 6. Oncologist. 2015. PMID: 25378456 Free PMC article. Clinical Trial.

8

The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.

Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. Tham YL, et al. Am J Clin Oncol. 2007 Apr;30(2):126-32. doi: 10.1097/01.coc.0000251398.57630.4f. Am J Clin Oncol. 2007. PMID: 17414460

9

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Tham YL, et al. Cancer. 2006 Aug 15;107(4):696-704. doi: 10.1002/cncr.22041. Cancer. 2006. PMID: 16826579 Free article.

10

Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.

Tham YL, Hinckley L, Teh BS, Elledge R. Tham YL, et al. Clin Breast Cancer. 2006 Jun;7(2):164-6. doi: 10.3816/CBC.2006.n.028. Clin Breast Cancer. 2006. PMID: 16800978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results